Natural and vaccine-induced antibody and cellular responses against emerging SARS-CoV-2 variants of concern by Skelly, D, Harding, AC, Gilbert-Jaramillo, J, Knight, ML, Longet, S, Brown, A, Adele, S, Adland, E, Brown, H, Medawar Laboratory Team, Tipton, T, Stafford, L, Johnson, S, Amini, A, OPTIC Clinical Group, Tan, TK, Schimanski, L, Huang, K-Y, Rijal, P, PITCH Study Group, University of Oxford, Frater, J, Goulder, P, Conlon, CP, Jeffery, K, Dold, C, Pollard, A, Townsend, A, Klenerman, P, Dunachie, S, Barnes, E, Carroll, MW, James, WS

Two doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concern by Skelly, DT, Harding, AC, Gilbert-Jaramillo, J, Knight, M, Longet, S, Brown, A, Adele, S, Adland, E, Brown, H, Medawar Laboratory Team, Tipton, T, Stafford, L, Johnson, S, Amini, A, OPTIC Clinical Group, Kit Tan, T, Schimanski, L, Huang, K-Y, Rijal, P, PITCH Study Group, Cmore Phosp-C Group, Frater, J, Goulder, P, Conlon, C, Jeffery, K, Dold, C, Pollard, A, Sigal, A, Oliveira, TD, Townsend, A, Klenerman, P, Dunachie, S, Barnes, E, Carroll, M, James, WS